文献速递主动脉疾病外周动脉疾病

单侧股动脉入路在髂动脉闭塞性疾病患者中行开窗/分支腔内主动脉修复

Fenestrated/branched endovascular aortic repair using unilateral femoral access in patients with iliac occlusive disease.
PubMed 文献 · J Vasc Surg · 2022-11-11

该回顾性研究纳入两家机构2003至2021年连续行开窗/分支腔内主动脉修复(F/BEVAR)的959例患者,其中15例(1.56%)存在单侧髂股动脉闭塞性疾病并利用对侧通畅髂动脉入路完成手术。技术成功率100%,30天死亡1例(7%),主要不良事件发生率20%,中位随访12个月,结论认为该技术可行但缺血并发症发生率较高。

要点

  • 单侧髂股动脉闭塞患者行F/BEVAR,技术成功率100%,30天死亡率7%。
  • 主要不良事件发生率20%,无术中及早期下肢缺血并发症。
  • 中位随访12个月,2例(13%)需三次再干预,总体生存率60%。

核心结论

  • 尽管具有挑战性,对髂动脉闭塞患者采用单侧股动脉/肱动脉入路行F/BEVAR是可行的,缺血并发症发生率较高但结局满意。

研究设计与样本

  • 回顾性综述,纳入两家机构2003至2021年连续行F/BEVAR的患者,分析其中单侧髂股动脉闭塞性疾病患者的技术策略与结局。

主要发现

  • 959例F/BEVAR患者中15例(1.56%;平均年龄74岁;80%男性)存在髂动脉闭塞且仅有一侧通畅髂股动脉入路,治疗胸腹主动脉瘤8例、近肾腹主动脉瘤7例。
  • 15例中14例使用肱动脉入路,7例(47%)使用预装导管/导丝系统,其余53%采用支架移植物交错释放。
  • 使用医师改良腔内移植物7例、定制器械7例、现货器械1例;13例(87%)采用主-单髂支架移植物远端密封,2例(13%)在肾下主动脉远端密封。
  • 2例同期行股动脉交叉旁路(FCB),6例既往有FCB;技术成功100%,无术中并发症或早期下肢缺血并发症,所有FCB均保留。
  • 30天内死亡1例(7%),原因为逆行性A型夹层;主要不良事件发生率20%;中位随访12个月(范围0-85个月)。

临床怎么用

  • 作者认为,对髂动脉闭塞患者采用单侧股动脉/肱动脉入路行F/BEVAR是可行的,尽管缺血并发症发生率较高但结局满意。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fenestrated/branched endovascular aortic repair (F/BEVAR) in patients with occluded iliac arteries is challenging owing to limited access for branch vessel catheterization and increased risk for leg and spinal ischemic complications. The aim of this study was to analyze technical strategies and outcomes of F/BEVAR in patients with unilateral iliofemoral occlusive disease. METHODS: We performed a retrospective review of all consecutive patients treated by F/BEVAR in two institutions (2003-2021). Patients with unilateral iliofemoral occlusive disease were included in the analysis. All patients had one patent iliac artery that was used for advancement of the fenestrated-branch component. Preloaded catheter/guidewire systems or steerable sheaths were used as adjuncts to facilitate catheterization. Primary endpoints were technical success, mortality, major adverse events (stroke, spinal cord injury, dialysis or decrease in the glomerular filtration rate of more than 50%, bowel ischemia, myocardial infarction, or respiratory failure), primary iliac patency, and freedom from reinterventions. RESULTS: There were 959 patients treated with F/BEVAR. Of these, 15 patients (1.56%; mean age, 74 years; 80% male) had occluded iliac arteries and 1 patent iliofemoral access and were treated for a thoracoabdominal aortic aneurysm (n = 8) or juxtarenal abdominal aortic aneurysm (n = 7). Brachial access was used in 14 of the 15 patients and preloaded systems in 7 of the 15 patients (47%). The remaining 53% had staggered deployment of stent grafts. There were seven physician-modified endovascular grafts, seven custom-made devices, and one off-the-shelf device used. Thirteen patients (87%) had distal seal using aortouni-iliac stent grafts and two (13%) had distal seal in the infrarenal aorta. Concomitant femoral crossover bypass (FCB) was performed in two patients and six patients had a prior FCB. Technical success was 100%. There were no intraoperative complications or early lower extremity ischemic complications, and all FCB were preserved. There was one mortality (7%) within 30 days owing to retrograde type A dissection. Major adverse events occurred in 20% of patients. The median follow-up was 12 months (range, 0-85 months). Two patients (13%) required three reinterventions. One patient required proximal stent graft extension for an acute type B dissection (3 months) and another required iliac extension for type Ib endoleak of an aortouni-iliac graft (21 months) and thrombolysis of that extension (50 months). At last follow-up, all patients had primary graft patency except one with secondary graft patency without new claudication. One patient had a single renal artery stent occlusion at follow-up with no r-intervention. The overall survival rate was 60%, without aortic-related deaths. CONCLUSIONS: Although challenging, F/BEVAR with unilateral femoral/brachial approach is feasible in patients with occluded iliac limbs, with an important rate of ischemic complications, but satisfactory outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rogers RT, Lemmens CC, Tenorio ER, et al. Fenestrated/branched endovascular aortic repair using unilateral femoral access in patients with iliac occlusive disease. J Vasc Surg. 2022. PMID: 36372375. doi:10.1016/j.jvs.2022.10.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。